News

Video

Envision Summit 2025: Understanding hyperglycemia in diabetic retinopathy

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

Kelly Donovan, MD:

Hi, I'm Kelly Donovan. I'm a senior ophthalmology resident at Duke Eye Center, and I'll be a medical retina fellow this coming year. Today, at the Envision conference, I spoke about some of my graduate research. We were looking at the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease. And we were looking at how hyperglycemia directly up regulates ophthalmology's favorite molecule, vascular endothelial growth factor A, or VEGF A. Which is exciting, because if we're able to understand how this happens, then it gives us the opportunity to intervene earlier in disease, and like many other diseases in the body, diabetic retinopathy is very multifactorial, and in my opinion, treatment of one target is probably not enough, and like cancer, we have to take a multipronged approach in order to have really significant efficacy to benefit patients. But right now that's limited, because we don't yet understand disease, and so more research will be necessary in the future to help us move towards that goal.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.